SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-16-013942
Filing Date
2016-06-01
Accepted
2016-06-01 13:20:08
Documents
63
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0316_amarantusbio.htm 10-Q 476256
2 CERTIFICATION f10q0316ex31i_amarantusbio.htm EX-31.1 11518
3 CERTIFICATION f10q0316ex31ii_amarantusbio.htm EX-31.2 11318
4 CERTIFICATION f10q0316ex32i_amarantusbio.htm EX-32.1 2942
5 CERTIFICATION f10q0316ex32ii_amarantusbio.htm EX-32.2 3206
  Complete submission text file 0001213900-16-013942.txt   4331958

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE ambs-20160331.xml EX-101.INS 889651
7 XBRL SCHEMA FILE ambs-20160331.xsd EX-101.SCH 54002
8 XBRL CALCULATION FILE ambs-20160331_cal.xml EX-101.CAL 35376
9 XBRL DEFINITION FILE ambs-20160331_def.xml EX-101.DEF 234973
10 XBRL LABEL FILE ambs-20160331_lab.xml EX-101.LAB 427458
11 XBRL PRESENTATION FILE ambs-20160331_pre.xml EX-101.PRE 306270
Mailing Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111
Business Address 655 MONTGOMERY STREET SUITE 900 SAN FRANCISCO CA 94111 (408) 737-2734
Amarantus Bioscience Holdings, Inc. (Filer) CIK: 0001424812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55016 | Film No.: 161688630
SIC: 2834 Pharmaceutical Preparations